Koshinski Asset Management
IBIO icon

Koshinski Asset Management’s iBio IBIO Stock Holding History

Koshinski Asset Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12
Closed -$2.57K – 1220
2022
Q1 		$2.57K Buy
12
+8
+200% +$1.67K ﹤0.01% 1931
2021
Q4 		$1.1K Hold
4
– – ﹤0.01% 2066
2021
Q3 		$2.12K Buy
+4
New +$2.49K ﹤0.01% 2010

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Koshinski Asset Management's IBIO Position: Q2 2022 in Review

Koshinski Asset Management sold out of iBio (IBIO) in Q2 2022, closing a stake of 12 shares — an estimated $2.57K sold.

Koshinski Asset Management first reported a position in IBIO in Q3 2021 and held it in 3 quarters. The position peaked at $2.57K in Q1 2022. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Koshinski Asset Management reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 12 iBio shares in Q2 2022, an estimated $2.57K.
  • Koshinski Asset Management first reported a position in iBio in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's iBio position peaked at $2.57K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.